Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs11633549 | chr15:25134049 | G/C | 5.07E-7 | 176 | 25.6 | 25.63 | 9.72 | KM Plot |
PCPG | rs11639566 | chr16:89890515 | C/G | 0.000192 | 173 | 25.87 | 21.5 | 36.37 | KM Plot |
PCPG | rs11639625 | chr16:89956253 | T/C | 0.000157 | 176 | 25.77 | 21.5 | 36.37 | KM Plot |
PCPG | rs11639774 | chr16:85221868 | G/A | 5.67E-9 | 172 | 25.6 | 24.23 | 15 | KM Plot |
PCPG | rs11639788 | chr16:89807543 | G/A | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs11639906 | chr16:89798183 | T/C | 0.00018 | 175 | 25.87 | 20.28 | 36.37 | KM Plot |
PCPG | rs11639925 | chr16:89908250 | C/T | 0.000182 | 173 | 25.87 | 23.37 | 36.37 | KM Plot |
PCPG | rs11640188 | chr16:89807732 | C/T | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs11640209 | chr16:89807828 | C/A | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs11640336 | chr16:89941153 | T/C | 0.000206 | 170 | 26.22 | 20.28 | 36.37 | KM Plot |
PCPG | rs11640899 | chr16:10078903 | A/G | 6.27E-5 | 177 | 24.6 | 30.93 | 21.58 | KM Plot |
PCPG | rs11641147 | chr16:89813589 | C/T | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs11641201 | chr16:89983276 | T/C | 0.00015 | 174 | 26.27 | 20.37 | 3.17 | KM Plot |
PCPG | rs11641552 | chr16:89838700 | C/A | 0.000168 | 177 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs11641631 | chr16:89993204 | C/A | 1.11E-16 | 171 | 25.87 | 20.28 | 3.17 | KM Plot |